The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Role of neurotrophic factors in depression
Abstract
Major depression is associated with reduced volumes in the hippocampus and prefrontal cortex, whereas antidepressant treatments promote several forms of neuronal plasticity, including neurogenesis, synaptogenesis and neuronal maturation, in the hippocampus. Several neurotrophic factors are associated with depression or antidepressant action. Stress suppresses brain-derived neurotrophic factor (BDNF) synthesis in the hippocampus, at least partially through a sustained modification of chromatin structure. Essentially all antidepressant treatments increase BDNF synthesis and signaling in the hippocampus and prefrontal cortex. This signaling is required for the behavioral effects of antidepressant drugs in rodents, and increased BDNF levels in the hippocampus mimic the behavioral effects of antidepressants. However, injection of BDNF into the mesolimbic dopamine pathway produces an opposing depression-like response. One hypothesis emerging from these data proposes that mood disorders reflect failed function of critical neuronal networks, whereas a gradual network recovery through activity-dependent neuronal plasticity induces the antidepressant effect. Neurotrophic factors themselves do not control mood, but they act as necessary tools in the activity-dependent modulation of networks, the physiological function of which determines how a plastic change influences mood.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These results lend substantial support to the neuroplasticity hypothesis of depression (sometimes referred to as the neurotrophin hypothesis) (11, 23–36).”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [28]
In the citing paper
“A growing body of research suggests that neuroplasticity pathways play a significant role in the pathophysiology of depression and in the therapeutic mechanisms of antidepressant drugs (AD) [1,2,3].”
Citations
Cites
Neurotrophins: Roles in Neuronal Development and Function
Huang, E. J., & Reichardt, L. F. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.677 · Cited by 4,394
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375
Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress
Berton, O., McClung, C. A., DiLeone, R. J., Krishnan, V., Renthal, W., Russo, S. J., Graham, D., Tsankova, N. M., Bolanos, C. A., Rios, M., et al. (2006) · Science · doi:10.1126/science.1120972 · Cited by 2,129
The mesolimbic dopamine reward circuit in depression
Nestler, E. J., & Carlezon, W. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.018 · Cited by 2,059
Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action
Tsankova, N. M., Berton, O., Renthal, W., Kumar, A., Neve, R. L., & Nestler, E. J. (2006) · Nature Neuroscience · doi:10.1038/nn1659 · Cited by 1,780
Increased hippocampal bdnf immunoreactivity in subjects treated with antidepressant medication
Chen, B., Dowlatshahi, D., MacQueen, G. M., Wang, J.-F., & Young, L. T. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01083-6 · Cited by 1,164
Shimizu, E., Hashimoto, K., Okamura, N., Koike, K., Komatsu, N., Kumakiri, C., Nakazato, M., Watanabe, H., Shinoda, N., Okada, S.-I., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00181-1 · Cited by 1,151
Saarelainen, T., Hendolin, P., Lucas, G., Koponen, E., Sairanen, M., MacDonald, E., Agerman, K., Haapasalo, A., Nawa, H., Aloyz, R., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-01-00349.2003 · Cited by 800
Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment
Warner‐Schmidt, J. L., & Duman, R. S. (2006) · Hippocampus · doi:10.1002/hipo.20156 · Cited by 787
Flagged first, then by citations
Cited by
Sorted by citations
Items 601–667 of 667
Brain galanin sytems and their role in depression-like behaviour
Kuteeva, E. (2007) · Figshare · Cited by 1
Early environmental manipulations and long‐term effects on brain neurotrophin levels
Cirulli, F., & Alleva, E. (2016) · Wiley eBooks · doi:10.1002/9781118931684.ch7 · Cited by 2
Neuron-Glia Signaling Regulates the Onset of the Antidepressant ResponsePreprint
Yao, V., Aly, A., Kalik, S., Gresack, J. E., Wang, W., Handler, A., Schaefer, A., Troyanskaya, O. G., Greengard, P., & Chottekalapanda, R. U. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.23.453443 · Cited by 1
Vanderzwet, K. (2015) · doi:10.22215/etd/2015-10820 · Cited by 1
Specific Mental Health Disorders: Depressive and Anxiety Disorders
Hickie, I. B. (2008) · Elsevier eBooks · doi:10.1016/b978-012373960-5.00048-4 · Cited by 1
The Interactive Effects of Ketamine and Magnesium Upon Depressive-like Pathology
Razmjou, S. (2014) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2014-10484 · Cited by 1
Dynamic changes in the development of prefrontal networks : neuroanatomical findings
Witte, A. V. (2007) · Publikationen an der Universität Bielefeld (Universität Bielefeld)
Differentiation of neural stem cells in fragile X syndrome
Tervonen, T. A. (2008) · Työväentutkimus Vuosikirja
BDNF-mediated modulation of glycine transmission on rat spinal motoneurons
Ding, J., Tang, X., Shi, J., & Jia, L. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.06.040
Papel do antidepressivo amitriptilina sobre a resposta inflamatória aguda em ratos
Vismari, L. (2010) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.47.2010.tde-16042010-155901
Epigenetics and Affective Disorder
王, 长. (2012) · International Journal of Psychiatry and Neurology · doi:10.12677/ijpn.2012.13007
Kozisek, M. E., Qutna, N. M., & Bylund, D. B. (2009) · The Open Pharmacology Journal · doi:10.2174/1874143600903010001
Moghadas, M., Edalatmanesh, M. A., & Hosseini, M. (2014) · The Neuroscience Journal of Shefaye Khatam · doi:10.18869/acadpub.shefa.2.4.9
Exercise for the brain. Just do it.
Bloor, E. K., & Bloor, P. O. (2013)
INVESTIGAÇÃO DO POTENCIAL ANTIDEPRESSIVO DE ROSMARINUS OFFICINALIS
Machado, D. G. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Ceretta, L. B. (2011) · Americanae (AECID Library)
Epigenetics and Affective Disorder
Wang, C., Zhang, X., Pan, Y.-J., Lv, Q., Li, Y., & Yang, J. (2012)
DEPRESSION AND BIPOLAR DISORDERS
Berrettini, W. H. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3291-5.50057-3
Ivanets, N. N., Tikhonova, Y. G., Kinkulkina, M. A., & Avdeeva, T. I. (2015)
The serotonin transporter and animal models of depression
Popa, D., Alexandre, C., Adrien, J., & Léna, C. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511729935.006
Adibfar, A. (2016) · TSpace (University of Toronto)
Zhang, L., Chen, Y., Sun, G., Zhang, L., Hu, D., & Zhe, W. (2018) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v16i11.25
Vagus nerve stimulation as a therapy for treatment resistant depression
Martínez, A. M. (2017) · Repositori digital de la UPF (Universitat Pompeu Fabra)
Kyeremanteng, C. (2012) · uO Research (University of Ottawa) · doi:10.20381/ruor-5452
Envolvimento do óxido nítrico na metilação do DNA induzida por estresse
Maciel, I. D. S. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2018.tde-25072018-094208
LEHMANN, D., Ludolph, A., Wurster, C. D., & Graf, H. (2018) · Nervenheilkunde · doi:10.1055/s-0038-1675711
dos Santos, J. C. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2020.tde-20112018-110709
BDNF level role in formation of cognitive violations at middle-aged persons
Пепеляев, Е. Г., Semenov, V. A., & Громова, О. А. (2020) · Pharmacokinetics and Pharmacodynamics · doi:10.37489/2587-7836-2020-2-37-41
The use of lithium ascorbate in middle-aged individuals with cognitive dysfunction
Yanko, E., Пепеляев, Е. Г., Ведмедь, Г. Н., & Семенов, В. А. (2020) · JOURNAL of SIBERIAN MEDICAL SCIENCES · doi:10.31549/2542-1174-2020-4-38-45
Methylmercury Exposure and Developmental Neurotoxicity: New Insights from Neural Stem Cells
Bose, R., Spulber, S. D., & Ceccatelli, S. (2021) · Springer eBooks · doi:10.1007/978-3-030-71519-9_235-1
Behavioural and molecular effects induced by Cannabidiol in animal models of depression
Silote, G. P. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.60.2021.tde-29092021-060118
Baker, G. B., & Mitchell, N. (2012) · Chemical biology · doi:10.1002/9781118435762.ch14
Gene-Environment Interactions, Stress, and Depression
Cohen‐Woods, S., & Harkess, K. N. (2016) · Springer eBooks · doi:10.1007/978-981-287-206-7_41
Molecular mechanisms of neurodegeneration in neuropsychiatric diseases
Farooqui, A. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821711-5.00005-x
Advances in Depression and Brain-Derived Neurotrophic Factor
Lin, H., Wu, K., Zhang, X.-G., Huang, X., Wu, C.-Y., & Cai, H. (2022) · Journal of Behavioral and Brain Science · doi:10.4236/jbbs.2022.126018
Сафарова, Т. П., Si, G., & Yakovleva, O. B. (2023) · Psikhiatriya · doi:10.30629/2618-6667-2022-20-4-6-13
Miranda, D. O. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.22.2014.tde-03022015-153825
Effects of psychedelics on neurogenesis and brain plasticity: A systematic reviewPreprint
da Cruz, R. V. L., Leão, R. N., & Moulin, T. C. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.19.549676
HEAVY METAL MUSIC, HIP-HOP MUSIC AND CONSTRUCTION NOISE INDUCES DEPRESSIVE SYMPTOMS IN MICE
Ren, J., & Lu, J. (2024) · ASEAN Journal of Psychiatry · doi:10.54615/2231-7805.47377
Cognitive impairment in patients with Parkinson’s disease
Катунина, Е. А., Parusova, A. V., Golovanova, I. V., & Zavadtseva, N. V. (2024) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202412411181
Ndavoumta, D., Foyet, H. S., Camdi, G. W., Defo, S. H. T., Abaïssou, H. H. N., Rebe, R. N., Kodji, K., Abengue, D. W., & Bum, E. N. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5131939
Cognitive Impairment in Patients with Parkinson’s Disease
Катунина, Е. А., Parusova, A. V., Golovanova, I. V., & Zavadtseva, N. V. (2025) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-025-01820-0
Ndavoumta, D., Foyet, H. S., Camdi, G. W., Defo, S. H. T., Abaïssou, H. H. N., Rebe, R. N., Kodji, K., Abengue, D. W., & Bum, E. N. (2025) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2025.07.014
Saayman, J. L. B., Harvey, B. H., Wegener, G., & Brink, C. B. (2024) · Suid-Afrikaanse Tydskrif vir Natuurwetenskap en Tegnologie · doi:10.36303/satnt.2024.43.1.977
Saayman, J. L. B., Harvey, B. H., Wegener, G., & Brink, C. B. (2024) · Suid-Afrikaanse Tydskrif vir Natuurwetenskap en Tegnologie · doi:10.36303/satnt.2024.43.1.977e
Research Progress on Anti-Depression Mechanism of Spleen-Wan Powder and Its Active Components
刘, 雅. (2023) · Traditional Chinese Medicine · doi:10.12677/tcm.2023.124124
Правикова, П. Д., & Naumenko, V. S. (2025) · Neurochemical Journal · doi:10.1134/s1819712425700357
Zhu, Z., Yang, J., Dai, D., Zhang, L., Zhang, Y., Yin, X., Cai, Y., Li, H., & Tao, W. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07612-7
Fakheri, S. T., Changizi, R., Manouchehri, H., Emran, A. T. N., Ahangarkolaei, M. N., Saeedi, M., & Siahposht-Khachaki, A. (2026) · Journal of Applied Toxicology · doi:10.1002/jat.70092
Efficacy and safety of Cortexin as additional therapy in patients with depressive disorder
Schastnyy, E. D. (2026) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202612602192
Ibargüen-Vargas, Y. (2008) · theses.fr (ABES) · doi:10.70675/2d73c017z46fcz4c35z8397zb504072e069a
Takahashi, K., Kurokawa, K., Kawaguchi, R., Takeda, H., & Tsuji, M. (2026) · Neurochemistry International · doi:10.1016/j.neuint.2026.106152
Brivio, P., Palumbo, A., Gallo, M. T., Veronesi, F. U. T., Cortinovis, G., Gruca, P., Łasoń, M., Litwa, E., Biała, D., Fumagalli, F., et al. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70594 · Cited by 1
Efficacy and Safety of Cortexin as Additional Therapy in Patients with Depressive Disorder
Schastnyy, E. D. (2026) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-026-02043-7
Ni, J., Qiao, M.-X., Lin, Y.-G., Yu, H., & Li, T. (2026) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2026.08.001
Demirtaş, D., Gülcen, B., & Çalışkan, H. (2026) · Biology · doi:10.3390/biology15201855
Dagestad, G. (2010) · NORA - Norwegian Open Research Archives
Metadata
- Authors
- CASTREN, E., VOIKAR, V, & RANTAMAKI, T.
- Venue
- Current Opinion in Pharmacology
- Publisher
- Elsevier BV
- Published
- 2007-02
- Volume
- 7
- Issue
- 1
- Pages
- 18-21
- ISSN
- 1471-4892 (ISSN-L)
- OpenAlex
- W1993636230
- Cited by
- 667
- References
- 32
- Citations by year
- 2026: 8 · 2025: 18 · 2024: 17 · 2023: 20 · 2022: 13 · 2021: 24 · 2020: 30 · 2019: 23 · 2018: 31 · 2017: 32 · 2016: 33 · 2015: 57 · 2014: 38 · 2013: 40 · 2012: 59
- FWCI
- 25.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- neurotrophic factors, major depressive disorder, brain-derived neurotrophic factor, antidepressant mechanism, hippocampus, prefrontal cortex, neuroplasticity, neurogenesis, synaptogenesis, chronic stress, chromatin structure, mesolimbic dopamine system, activity-dependent plasticity, mood disorders
- MeSH terms
- Animals, Antidepressive Agents, Depression, Humans, Nerve Growth Factors, Stress, Physiological, Mood Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review